Eton Pharmaceuticals ETON Stock
Eton Pharmaceuticals Price Chart
Eton Pharmaceuticals ETON Financial and Trading Overview
| Eton Pharmaceuticals stock price | 12.5 USD |
| Previous Close | 3.6 USD |
| Open | 3.64 USD |
| Bid | 3.56 USD x 500 |
| Ask | 3.65 USD x 100 |
| Day's Range | 3.54 - 3.65 USD |
| 52 Week Range | 2.42 - 5.81 USD |
| Volume | 224.45K USD |
| Avg. Volume | 66.24K USD |
| Market Cap | 91.97M USD |
| Beta (5Y Monthly) | 1.186 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.15 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 8 USD |
ETON Valuation Measures
| Enterprise Value | 72.18M USD |
| Trailing P/E | N/A |
| Forward P/E | 13.259258 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.906654 |
| Price/Book (mrq) | 5.9468436 |
| Enterprise Value/Revenue | 2.281 |
| Enterprise Value/EBITDA | -201.612 |
Trading Information
Eton Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 1.186 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 5.81 USD |
| 52 Week Low | 2.42 USD |
| 50-Day Moving Average | 3.54 USD |
| 200-Day Moving Average | 4.11 USD |
ETON Share Statistics
| Avg. Volume (3 month) | 66.24K USD |
| Avg. Daily Volume (10-Days) | 62.69K USD |
| Shares Outstanding | 25.69M |
| Float | 21.88M |
| Short Ratio | 1.61 |
| % Held by Insiders | 5.41% |
| % Held by Institutions | 28.87% |
| Shares Short | 87.36K |
| Short % of Float | 0.36% |
| Short % of Shares Outstanding | 0.33% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2023 |
| Most Recent Quarter (mrq) | December 31, 2023 |
| Next Fiscal Year End | December 31, 2024 |
Profitability
| Profit Margin | -2.95% |
| Operating Margin (ttm) | -27.25% |
| Gross Margin | 66.56% |
| EBITDA Margin | -1.13% |
Management Effectiveness
| Return on Assets (ttm) | -2.62% |
| Return on Equity (ttm) | -6.55% |
Income Statement
| Revenue (ttm) | 31.64M USD |
| Revenue Per Share (ttm) | 1.23 USD |
| Quarterly Revenue Growth (yoy) | -13.90% |
| Gross Profit (ttm) | N/A |
| EBITDA | -358000 USD |
| Net Income Avi to Common (ttm) | -936000 USD |
| Diluted EPS (ttm) | -0.04 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 21.39M USD |
| Total Cash Per Share (mrq) | 0.83 USD |
| Total Debt (mrq) | 5.46M USD |
| Total Debt/Equity (mrq) | 35.25 USD |
| Current Ratio (mrq) | 1.653 |
| Book Value Per Share (mrq) | 0.602 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 6.82M USD |
| Levered Free Cash Flow (ttm) | 5.6M USD |
Profile of Eton Pharmaceuticals
| Country | United States |
| State | IL |
| City | Deer Park |
| Address | 21925 W. Field Parkway |
| ZIP | 60010-7278 |
| Phone | 847 787 7361 |
| Website | https://www.etonpharma.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 30 |
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of tyrosinemia type 1. It also provides Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
Q&A For Eton Pharmaceuticals Stock
What is a current ETON stock price?
Eton Pharmaceuticals ETON stock price today per share is 12.5 USD.
How to purchase Eton Pharmaceuticals stock?
You can buy ETON shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Eton Pharmaceuticals?
The stock symbol or ticker of Eton Pharmaceuticals is ETON.
Which industry does the Eton Pharmaceuticals company belong to?
The Eton Pharmaceuticals industry is Drug Manufacturers-Specialty & Generic.
How many shares does Eton Pharmaceuticals have in circulation?
The max supply of Eton Pharmaceuticals shares is 26.82M.
What is Eton Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Eton Pharmaceuticals PE Ratio is now.
What was Eton Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Eton Pharmaceuticals EPS is -0.15 USD over the trailing 12 months.
Which sector does the Eton Pharmaceuticals company belong to?
The Eton Pharmaceuticals sector is Healthcare.
Eton Pharmaceuticals ETON included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16550.61 USD — |
-5.97
|
8.29B USD — | 16533.04 USD — | 16889.34 USD — | — - | 8.29B USD — |
| NASDAQ Global Market Composite NQGM | 1737.75 USD — |
-6
|
— — | 1724.84 USD — | 1770.8 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 920.53 USD — |
-2.33
|
— — | 917.85 USD — | 930.28 USD — | — - | — — |
- {{ link.label }} {{link}}